Epigenetic dysregulation in Epstein-Barr virus-associated gastric carcinoma: Disease and treatments

被引：53
|
作者：
Yau, Tung On [1 ,2 ]
Tang, Ceen-Ming [1 ,2 ,3 ]
Yu, Jun [1 ,2 ]
机构：
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, LKS Inst Hlth Sci, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
[3] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2014年 / 20卷 / 21期
关键词：
Epstein-Barr virus; Gastric carcinoma; Epigenetic dysregulation; Aberrant DNA methylation; Epigenetic therapies; HISTONE DEACETYLASE INHIBITORS; ISLAND METHYLATOR PHENOTYPE; DNA METHYLTRANSFERASE 1; MEMBRANE-PROTEIN; 2A; PROMOTER HYPERMETHYLATION; CANCER-CELLS; NASOPHARYNGEAL CARCINOMA; ABERRANT METHYLATION; SIGNALING PATHWAY; MICRORNA TARGETS;
D O I：
10.3748/wjg.v20.i21.6448
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) comprises nearly 10% of gastric carcinoma cases worldwide. Recently, it was recognised to have unique clinicopathologic characteristics, including male predominance, lower rates of lymph node involvement, and better prognosis. EBVaGC is further characterised by abnormal hypermethylation of tumour suppressor gene promoter regions, causing down-regulation of their expression. In the present review, we critically discuss the role of EBV in gastric carcinogenesis, summarising the role of viral proteins and microRNAs with respect to aberrant methylation in EBVaGC. Given the role of epigenetic dysregulation in tumourigenesis, epigenetic modifiers may represent a novel therapeutic strategy. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码：6448 / 6456
页数：9
相关论文
共 50 条
  • [31] Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma
    Fukayama, M
    Chong, JM
    Uozaki, H
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 91 - 102
  • [32] Epstein-Barr Virus-associated Gastric Carcinoma A Newly Defined Entity
    Chen, Jian-Ning
    He, Dan
    Tang, Fang
    Shao, Chun-kui
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (04) : 262 - 271
  • [33] Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma
    Yanai, H
    Nishikawa, J
    Mizugaki, Y
    Shimizu, N
    Takada, K
    Matsusaki, K
    Toda, T
    Matsumoto, Y
    Tada, M
    Okita, K
    GASTROINTESTINAL ENDOSCOPY, 1997, 45 (03) : 236 - 242
  • [34] Cancer stem cells in Epstein-Barr virus-associated gastric carcinoma
    Yasui, Mariko
    Kunita, Akiko
    Numakura, Satoe
    Uozaki, Hiroshi
    Ushiku, Tetsuo
    Fukayama, Masashi
    CANCER SCIENCE, 2020, 111 (07) : 2598 - 2607
  • [35] Expression of viral MicroRNAs in Epstein-Barr virus-associated gastric carcinoma
    Kim, Do Nyun
    Chae, Hiun-Suk
    Oh, Sang Taek
    Kang, Jin-Hyoung
    Park, Cho Hyun
    Park, Won Sang
    Takada, Kenzo
    Lee, Jae Myun
    Lee, Won-Keun
    Lee, Suk Kyeong
    JOURNAL OF VIROLOGY, 2007, 81 (02) : 1033 - 1036
  • [36] Epstein-Barr virus-associated gastric carcinoma in Papua New Guinea
    Morewaya, J
    Koriyama, C
    Akiba, S
    Shan, D
    Itoh, T
    Eizuru, Y
    ONCOLOGY REPORTS, 2004, 12 (05) : 1093 - 1098
  • [37] The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China
    Hao, ZF
    Koriyama, C
    Akiba, S
    Jing, L
    Luo, XM
    Itoh, T
    Eizuru, Y
    Zou, JM
    ONCOLOGY REPORTS, 2002, 9 (06) : 1293 - 1298
  • [38] EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC ADENOCARCINOMA IN TAIWAN
    HARN, HJ
    CHANG, JY
    WANG, MW
    LO, LI
    LEE, HS
    CHIANG, JH
    LEE, WH
    HUMAN PATHOLOGY, 1995, 26 (03) : 267 - 271
  • [39] Epstein-Barr Virus associated gastric carcinoma
    Oh, Hwa Eun
    Chetty, Runjan
    GENE THERAPY AND MOLECULAR BIOLOGY, 2007, 11A : 51 - 59
  • [40] Role of Viral miRNAs and Epigenetic Modifications in Epstein-Barr Virus-Associated Gastric Carcinogenesis
    Giudice, Aldo
    D'Arena, Giovanni
    Crispo, Anna
    Tecce, Mario Felice
    Nocerino, Flavia
    Grimaldi, Maria
    Rotondo, Emanuela
    D'Ursi, Anna Maria
    Scrima, Mario
    Galdiero, Massimiliano
    Ciliberto, Gennaro
    Capunzo, Mario
    Franci, Gianluigi
    Barbieri, Antonio
    Bimonte, Sabrina
    Montella, Maurizio
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
12345